Sotera Health (SHC) announced the appointment of Alton Shader to the role of CEO of the company, effective May 26, as part of a planned leadership transition. Shader will succeed Michael Petras, chairman and CEO, who will serve as executive chairman. “Alton’s strong commercial experience and track-record of driving growth in the healthcare industry makes him a great fit for Sotera Health,” said Michael Petras. Shader has served as CEO and director of Viant Medical since 2019 and brings over 20 years of deep medical industry experience. At Viant, he successfully led the company through a period of accelerated growth by expanding the global manufacturing footprint and strengthening its end-to-end capabilities through targeted acquisitions.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SHC:
- Sotera Health reports Q1 EPS 18c, consensus 17c
- Sotera Health backs FY26 adjusted EPS view 93c-$1.01, consensus 96c
- Sotera Health Names New CEO, Highlights Leadership Transition
- Sotera Health price target lowered to $18 from $20 at Barclays
- Sotera Health Adds Independent Director Amid Board Reshuffle
